{
    "startDate": "2022-01-01",
    "endDate": "2022-03-31",
    "year": "2022",
    "quarter": "Q1",
    "symbol": "BHVN",
    "data": {
        "bs": [
            {
                "label": "Marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 433410000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 576114000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 55910000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1171085000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 1371717000
            },
            {
                "label": "Trade receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 328342000
            },
            {
                "label": "Common shares, no par value; 200,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 70,540,802 and 66,933,531 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 2112686000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 41782000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 56202000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssets",
                "unit": "usd",
                "value": 130188000
            },
            {
                "label": "Mandatorily redeemable preferred shares, net",
                "concept": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent",
                "unit": "usd",
                "value": 162994000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 169065000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 169065000
            },
            {
                "label": "Prepaid expenses",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 104891000
            },
            {
                "label": "Prepaid expenses",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 104891000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -2702154000
            },
            {
                "label": "Contingently redeemable non-controlling interests",
                "concept": "RedeemableNoncontrollingInterestEquityCarryingAmount",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 457412000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 457412000
            },
            {
                "label": "Current portion of mandatorily redeemable preferred shares",
                "concept": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent",
                "unit": "usd",
                "value": 62500000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 44096000
            },
            {
                "label": "Derivative liability",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 9120000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 14534000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -2398000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 1838130000
            },
            {
                "label": "Obligation to perform R&D services",
                "concept": "bhvn:ObligationForServicesNoncurrent",
                "unit": "usd",
                "value": 36016000
            },
            {
                "label": "Long-term debt",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 634106000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 91281000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 91281000
            },
            {
                "label": "Non-controlling interests in consolidated subsidiaries",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -4127000
            },
            {
                "label": "Liability related to sale of future royalties, net",
                "concept": "bhvn:LiabilityForSaleOfFutureRoyaltiesCarryingAmountNoncurrent",
                "unit": "usd",
                "value": 377998000
            },
            {
                "label": "Total liabilities and shareholders\u2019 deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 1371717000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 129580000
            },
            {
                "label": "Total shareholders\u2019 deficit attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -462286000
            },
            {
                "label": "Total shareholders' deficit",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -466413000
            },
            {
                "label": "Total shareholders' deficit",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -466413000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebtExcludingAmortization",
                "unit": "usd",
                "value": 7917000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 267991000
            },
            {
                "label": "Prepaid expenses, other current assets, and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 24954000
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 23397000
            },
            {
                "label": "Gain from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in obligation to perform R&D services",
                "concept": "bhvn:ChangeInObligationToPerformResearchAndDevelopmentServices",
                "unit": "usd",
                "value": 6942000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 4518000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 246816000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 512000
            },
            {
                "label": "Net cash (used in) provided by investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -244270000
            },
            {
                "label": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": -46000
            },
            {
                "label": "Deferred interest paid-in-kind on long-term debt",
                "concept": "bhvn:NoncashInterestExpenseOnLongTermDebt",
                "unit": "usd",
                "value": 6450000
            },
            {
                "label": "Trade receivable, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 20073000
            },
            {
                "label": "Net increase in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 31000
            },
            {
                "label": "Accrued expenses, other current liabilities, and other liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
                "unit": "usd",
                "value": 48661000
            },
            {
                "label": "Change in fair value of derivatives",
                "concept": "bhvn:FairValueAdjustmentOfDerivativeLiability",
                "unit": "usd",
                "value": -3604000
            },
            {
                "label": "Issuance of common shares as payment for license agreement",
                "concept": "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "unit": "usd",
                "value": 1779000
            },
            {
                "label": "Proceeds from issuance of common shares",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 252000000
            },
            {
                "label": "Proceeds from exercise of share options",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 2803000
            },
            {
                "label": "Proceeds from the issuance of series B preferred shares",
                "concept": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
                "unit": "usd",
                "value": 14579000
            },
            {
                "label": "Other non-cash items",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": 646000
            },
            {
                "label": "Sales of marketable securities",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Sales of marketable securities",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Maturities of marketable securities",
                "concept": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 3058000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -23644000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 4402000
            },
            {
                "label": "Interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 17314000
            },
            {
                "label": "Interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 17314000
            },
            {
                "label": "Payments for term loan, finance leases, and other",
                "concept": "bhvn:RepaymentOfOtherLongTermDebtAndIssuanceCostFinanceLeasePaymentsAndOther",
                "unit": "usd",
                "value": 1391000
            },
            {
                "label": "Non-cash share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 81828000
            },
            {
                "label": "Non-cash share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 81828000
            },
            {
                "label": "Proceeds from obligation to perform R&D services",
                "concept": "bhvn:ProceedsFromServiceObligation",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "Interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 17314000
            },
            {
                "label": "Interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 17314000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -53832000
            },
            {
                "label": "Other comprehensive (loss) income, net of tax",
                "concept": "OtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -2325000
            },
            {
                "label": "Other comprehensive (loss) income, net of tax",
                "concept": "OtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -2325000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 227243000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 24303000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 24303000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 24303000
            },
            {
                "label": "Weighted average common shares outstanding - basic (shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Weighted average common shares outstanding - basic (shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 70332274
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": ""
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -2.97
            },
            {
                "label": "Total revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 318852000
            },
            {
                "label": "Net loss attributable to common shareholders of Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -209072000
            },
            {
                "label": "Net loss attributable to common shareholders of Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Change in fair value of derivatives",
                "concept": "bhvn:FairValueAdjustmentOfDerivatives",
                "unit": "usd",
                "value": -3604000
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -2.97
            },
            {
                "label": "Net loss per share attributable to Biohaven Pharmaceutical Holding Company Ltd - basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": ""
            },
            {
                "label": "Total operating expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 372684000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -119222000
            },
            {
                "label": "Interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebt",
                "unit": "usd",
                "value": 7917000
            },
            {
                "label": "Gain from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Research and development expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 119099000
            },
            {
                "label": "Comprehensive loss attributable to Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -118724000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -116897000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -92594000
            },
            {
                "label": "Cost of sales",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 26342000
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 81000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpenseOther",
                "unit": "usd",
                "value": 17216000
            },
            {
                "label": "Total other expense, net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -38762000
            },
            {
                "label": "Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -498000
            },
            {
                "label": "Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -498000
            },
            {
                "label": "Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -498000
            },
            {
                "label": "Deemed dividend upon repurchase of preferred shares in consolidated subsidiary",
                "concept": "PreferredStockDividendsIncomeStatementImpact",
                "unit": "usd",
                "value": 92673000
            },
            {
                "label": "Deemed dividend upon repurchase of preferred shares in consolidated subsidiary",
                "concept": "PreferredStockDividendsIncomeStatementImpact",
                "unit": "usd",
                "value": 92673000
            },
            {
                "label": "Weighted average common shares outstanding - diluted (shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 70332274
            },
            {
                "label": "Weighted average common shares outstanding - diluted (shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Less: comprehensive loss attributable to non-controlling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -498000
            }
        ]
    }
}